Feb 27, 2020 / 01:30PM GMT
Operator
Good day, ladies and gentlemen, and welcome to the NeoGenomics Fourth Quarter and Fiscal Year 2019 Earnings Release Conference call. (Operator Instructions)
At this time, it is my pleasure to turn the floor over to your host for today, CEO, Mr. Doug VanOort. Sir, the floor is yours.
Douglas M. VanOort - NeoGenomics, Inc. - Chairman & CEO
Thank you, Jess. Good morning, everyone. I'd like to welcome everyone to NeoGenomics' Fourth Quarter 2019 Conference call. Our team is here together in San Antonio at our Annual National Sales Meeting, and joining me for this call is Kathryn McKenzie, our Chief Financial Officer; Rob Shovlin, President of our Clinical Division; George Cardoza, President of our Pharma Services Division; Bill Bonello, President of our Informatics Division and Director of Investor Relations; Dr. Larry Weiss, our Chief Medical Officer; and Doug Brown, our Chief Strategy and Corporate Development Officer.
Before we begin our prepared remarks, Bill Bonello will read the standard language about forward-looking statements.
Q4 2019 Neogenomics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot